Explore the latest research, expert guidance, and practical tips on oral immunotherapy, allergen management, and living allergy-free.
CW39 Houston covers how OLLEREG sublingual immunotherapy sprays help families fight back against seasonal allergies — with Dr. Dat Tran explaining how the treatment works and why it's changing allergy care.
See the emotional transformations of families who struggled with severe allergies before discovering OLLEREG. From constant symptoms to breathing freely — hear their stories in their own words.
A comprehensive look at the evidence behind sublingual immunotherapy (SLIT) — from landmark clinical trials to modern meta-analyses — and why leading allergists now consider it a first-line treatment for allergic rhinitis.
Mountain cedar pollen counts in Texas regularly exceed 10,000 grains/m³ — among the highest recorded globally. Here's the science behind why cedar fever is so severe.
Corticosteroid nasal sprays are the most widely used allergy treatment in the world — but research consistently shows they manage symptoms without addressing the underlying immune dysfunction.
New studies show that sublingual immunotherapy can reduce pet allergy symptoms by up to 60%. Here's what the research says about building tolerance to Fel d 1 and Can f 1.
Timing matters. Research shows that starting SLIT 3-4 months before pollen season leads to significantly better outcomes than waiting until symptoms start.
A systematic review found SLIT to be significantly safer than subcutaneous immunotherapy, with no reported fatalities across 60+ clinical trials.
The FDA-approved ODACTRA tablet proved SLIT's efficacy for dust mites. New research shows multi-allergen sublingual formats may deliver comparable results.
A meta-analysis of 42 randomized controlled trials found SLIT to be both safe and effective in pediatric patients, with adverse events limited to mild oral itching.
Science-backed sublingual immunotherapy delivered to your door. No clinic visits, no injections.
Shop Sprays